论文部分内容阅读
目的:探讨奥曲肽治疗急性胰腺炎的临床疗效。方法:选取我院2012年3月至2016年级3月收治的56例急性胰腺炎患者为研究对象,将所有患者按照不同的治疗方法分为对照组26例和研究组30例,对照组患者给予常规治疗,研究组在对照组的基础上采用奥曲肽治疗,观察两组患者的临床疗效。结果:治疗后研究组患者的腹痛缓解时间、血淀粉酶正常时间、胰腺水肿消失时间以及住院时间显著低于对照组,两组比较差异有统计学意义(P<0.05),研究组治疗总有效率为96.7%,显著高于对照组的84.6%,研究组治疗总有效率明显高于对照组,两组比较差异有统计学意义(P<0.05)。结论:在常规治疗基础上联合应用奥曲肽治疗急性胰腺炎缓解症状快,治疗时间短,疗效可靠,值得临床进行推广应用。
Objective: To investigate the clinical efficacy of octreotide in the treatment of acute pancreatitis. Methods: A total of 56 patients with acute pancreatitis admitted to our hospital from March 2012 to March 2016 were selected as study subjects. All patients were divided into control group (n = 26) and study group (n = 30) according to different treatment methods. Patients in control group Routine treatment, the study group in the control group based on octreotide treatment, the clinical efficacy of two groups were observed. Results: After treatment, the pain relief time, the normal time of amylase, the time of disappearance of pancreatic edema and the length of hospital stay in the study group were significantly lower than those in the control group (P <0.05) The efficiency was 96.7%, significantly higher than 84.6% of the control group, the total effective rate of the study group was significantly higher than the control group, the difference between the two groups was statistically significant (P <0.05). Conclusion: The combined treatment of octreotide on the basis of conventional treatment of acute pancreatitis relieves symptoms quickly, the treatment time is short, and the curative effect is reliable. It is worth to be popularized and applied clinically.